BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
Boehringer Ingelheim (Austria) · Boehringer Ingelheim (Germany) · +1 more institution
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
849
total citations
- FWCI
- 16.46
- Percentile
- 100%
- References
- 26
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Polo-like kinase
- PLK1
- Biology
- Mitosis
- Kinase
- Cell cycle
- Cancer research
- Prometaphase
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.